A survey of treatment routines and educational level of health care providers in the initial phase of suspected acute myocardial infarction in Sweden in 1994

European Journal of Emergency Medicine

Volumn 3, Issue 3, 1996, Pages 149-156

[No Author Info available]

Author keywords

Acute myocardial infarction; Survey treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CLINICAL COMPETENCE; CLINICAL TRIAL; EDUCATION; EDUCATIONAL STATUS; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; QUESTIONNAIRE; RESCUE PERSONNEL; STANDARD; SWEDEN;

ADRENERGIC BETA-ANTAGONISTS; ASPIRIN; CLINICAL COMPETENCE; EDUCATIONAL STATUS; EMERGENCY MEDICAL SERVICES; EMERGENCY MEDICAL TECHNICIANS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; SWEDEN; THROMBOLYTIC THERAPY;

EID: 0030225468     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-199609000-00003     Document Type: Article

References (23)

1. Dellborg, M., Eriksson, P., Riha, M. and Swedberg, K. (1994) Declining hospital mortality in acute myocardial infarction. Eur. Heart J., 15, 5-9.
2. Eisenberg, M.S., Aghababian, R.V. and Bossaert, L. (1993) Thrombolytic therapy. Ann. Emerg. Med., 22, 417-27.
3. European Myocardial Infarction Project Group (1993) Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N. Engl. J. Med., 329, 383-9.
4. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet, 343, 311-22.
5. Gruppo Italiano per lo Studio della Streptochnasi nell'infarto miocardico (GISSI) (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet, 1, 397-401.
6. Guidelines for Management of AMI by the AHA (1990) Circulation, 82, 664-707.
7. Henning, R. and Lundman, T. (1975) Swedish co-operative CCU study. A study of 2008 patients with acute myocardial infarction from twelve Swedish hospitals with coronary care unit. Part I: A description of the early stage. Acta Med. Scand., (suppl 586), 1-64.
8. Herlitz, J., Elmfeldt, D., Hjalmarson, A., Holmberg, S., Malek, I., Nyberg, G., Ryden, L., Swedberg, K., Vedin, A., Waag-stein, E, Waldenstrom, A., Waldenstrom, J., Wedel, H., Wilhelmsen, L. and Wilhelmsson, C. (1983) Effect of meto-prolol on indirect signs of the size and severity of acute myocardial infarction. Am.J. Cardiol., 51, 1282-8.
9. Herlitz, J., Hjalmarson, A., Holmberg, S., Pennert, K., Swedberg, K., Vedin, A., Waagstein, F., Waldenstrom, A., Wedel, H., Wilhelmsen, L. and Wilhelmsson, C. (1984) Effect of metoprolol on chest pain in acute myocardial infarction. Br. Heart J., 51, 438-14.
10. Herlitz, J., Hartford, M., Aune, S., Karlsson, T. and Hjalmarson, A. (1993) Delay time between onset of myocardial infarction and start of thrombolysis in relation to prognosis. Cardiology, 82, 347-53.
11. Hjalmarson, A., Elmfeldt, D., Herlitz, J., Holmberg, S., Malek, I., Nyberg, G., Ryden, L., Swedberg, K., Vedin, A., Waagstein, F., Waldenstrom, A., Waldenstrom, J., Wedel, H., Wilhelmsen, L. and Wilhelmsson, C. (1981) Effect on mortality of metroprolol in acute myocardial infarction. Lancet, 2, 823-7.
12. International Collaborative Study Group (1984) Reduction of infarct size with the early use of timolol in acute myocardial infarction. N. Engl. J. Med., 310, 9-14.
13. International Study Group (1990) In-hospital mortality and clinical course of 20.891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. Lancet, 336, 71-5.
14. ISIS-1 Collaboration Group (1986) Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet, 2, 57-66.
15. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or either among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet, 2, 349-60.
16. Karlson, B.W., Herlitz, J., Edvardsson, N., Emanuelsson, H., Sjolin, M. and Hjalmarson, A. (1990) Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation, 82, 1140-6.
17. MacCallum, A.G., Stafford, P.J., Jones, C., Vincent, R., Perez-Avila, C. and Chamberlain, D.A. (1990) Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur. Heart]., 11, (suppl F), 48-52.
18. Maroko, P.R., Kjekshus, J.K., Sobel, B.E., Watanabe, T., Covell, J.W., Ross Jr, J. and Braunwald, E. (1971) Factors influencing infarct size following experimental coronary artery occlusions. Circulation, 43, 67-82.
19. Risenfors, M., Herlitz, J., Berg, C-H., Dellborg, M., Gustavsson, G., Gottfridsson, C., Lomsky, M., Swedberg, K. and Hjalmarson, A. (1991) Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT-Study. J. Intern. Med., 229, (suppl 1), 35-12.
20. Thrombolysis Early in Acute Heart Attack Trial (TEAHAT) Study Group (1990) Very early thrombolytic therapy in suspected acute myocardial infarction. Am.J. Cardiol., 65, 401-7.
21. Van de Werf, F. and Arnold, A.E.R. (1988) Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. Br. Med.J., 297, 1374-9.
22. Waagstein, F. and Hjalmarson, A.C. (1975) Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction. Acta Med. Scand., (suppl 587), 201-8.
23. Weaver, W.D., Cerqueira, M., Hallstrom, A.P., Litwin, P.E., Martin, J.S., Kudenchuk, P.J. and Eisenberg, M. For the myocardial infarction triage and intervention project group (1993) Prehospital-initiated vs hospital initiated thrombolytic therapy. The myocardial infarction triage and intervention trial. J.A.M.A., 270, 1211-16.